Wave Life Sciences to Webcast Conference Call of First Quarter 2021 Financial Results on May 13, 2021

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE) will host a live webcast and conference call on May 13, 2021, at 8:30 a.m. ET to discuss its Q1 2021 financial results and provide a business update. This event will be accessible via their Investor Relations page. As a clinical-stage genetic medicines company, Wave focuses on innovative treatments for serious diseases through its proprietary PRISM platform that enhances the design and production of stereopure oligonucleotides.

Positive

• Upcoming conference call to discuss Q1 2021 financial results indicates transparency and communication with investors.

Negative

• None.

CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Thursday, May 13, 2021, to discuss its first quarter 2021 financial results and provide a business update.

The webcast of the conference call may be accessed by visiting the “Events” section in the Investor Relations page of the Wave Life Sciences website at www.wavelifesciences.com. The live teleconference may be accessed by dialing (866) 220-8068 (domestic) or (352) 225-7726 (international) and entering conference ID: 7430859. Following the conference call, an archived version of the call will be available on the website. 

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com  

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com 

FAQ

When will Wave Life Sciences announce its Q1 2021 financial results?

Wave Life Sciences will announce its Q1 2021 financial results on May 13, 2021.

How can I access the Wave Life Sciences conference call?

You can access the Wave Life Sciences conference call by visiting the Investor Relations page on their website or by dialing the provided conference numbers.

What does Wave Life Sciences focus on?

Wave Life Sciences focuses on developing genetic medicines for serious diseases using its PRISM platform.